Side-by-side guides — peptide vs peptide, app vs app, method vs method. No marketing spin, no sponsored ranking.
Feature-by-feature comparison of the two iPhone peptide trackers: logging depth, free tools, and pricing.
Which iPhone tracker covers more peptides, has free web tools, and ships a researched library?
Calculator-first tool vs full tracker + library. Where each one fits.
Bare-bones logger or a researched protocol tracker with free dose tools? Side-by-side breakdown.
GLP-1 injection logger vs broader peptide tracker covering 30+ compounds and stacks.
Two peptide trackers compared on library depth, free tools, and long-term usability.
Simple log vs researched reference + calculators. Which matches how you actually run a protocol?
Thinking about tracking your protocol without a dedicated app? Honest breakdowns of the three most common alternatives.
Where Excel and Google Sheets hold up, where they break (titration, site rotation, reminders), and when to switch.
Notes as a side-effect journal vs a structured tracker with dose math and reminders.
Static recurring reminders vs protocol-aware scheduling with titration, rotation, and inventory.
Side-by-side comparisons of commonly-considered alternatives. Mechanism, dosing, evidence, and where each wins.
GLP-1 monotherapy vs GLP-1/GIP co-agonism. Efficacy, dosing, and the SURPASS vs STEP trial context.
Approved weekly GLP-1 vs phase-3 triple agonist. What the TRIUMPH data show.
Dual vs triple receptor co-agonism — mechanism, efficacy, and safety.
Two leading soft-tissue repair compounds — and when stacking both makes sense.
Dermatology-leaning copper tripeptide vs GI/systemic repair peptide.
GHRH analog vs selective GHRP — why they are usually stacked rather than chosen.
Two GHRH analogs compared on half-life, dosing cadence, and pulsatility.
FDA-approved GHRH analog for HIV lipodystrophy vs the older GHRH (1-29) analog.
Selective GHRP vs cortisol/prolactin-releasing classic — selectivity trade-offs.
Hunger-neutral GHRP vs the appetite-stimulating classic.
Mild selective GHRP vs the most potent GHRP — and why potency has a cost.
Melanocortin agonists with different selectivity profiles — libido vs pigmentation.